Chemomab Therapeutics Ltd.

CIK 1534248 · 369 filings in 53 form types · 2011-11-07 to 2026-11-19 · CMMB

Former names: Anchiano Therapeutics Ltd.; BioCancell Ltd.

FiledFormCategory8-K items / descriptionAccession
2026-11-19 6-K Current reports 6-K 0001178913-26-005292
2026-11-10 SCHEDULE 13D Ownership 0001493152-26-051041
2026-11-10 DEFA14A Proxies 0001493152-26-051035
2026-11-03 6-K Current reports 6-K 0001178913-26-004976
2026-10-30 EFFECT Registrations and prospectuses 9999999995-26-003389
2026-10-30 DEFM14A Proxies 0001493152-26-049444
2026-10-29 S-4/A Registrations and prospectuses 0001493152-26-049306
2026-10-19 S-4/A Registrations and prospectuses 0001493152-26-047625
2026-10-19 6-K Current reports 6-K 0001178913-26-004796
2026-09-30 6-K Current reports 6-K 0001178913-26-004676
2026-09-25 S-4 Registrations and prospectuses 0001493152-26-044397
2026-09-09 SCHEDULE 13D/A Ownership 0001104659-26-106301
2026-09-01 4 Ownership 0001178913-26-004371
2026-08-19 6-K Current reports 6-K 0001178913-26-004193
2026-08-13 SCHEDULE 13G Ownership 0002148623-26-000001
2026-08-12 DRS Other 0001493152-26-037222
2026-08-10 SCHEDULE 13G/A Ownership 0001995601-26-000004
2026-07-16 SCHEDULE 13D Ownership 0001104659-26-084244
2026-07-08 6-K Current reports 6-K 0001178913-26-003442
2026-06-03 3 Ownership 0001178913-26-003083
2026-06-02 6-K Current reports 6-K 0001178913-26-003058
2026-06-01 4 Ownership 0001178913-26-003004
2026-05-14 6-K Current reports 6-K 0001178913-26-002672
2026-05-06 6-K Current reports 6-K 0001178913-26-002423
2026-04-28 6-K Current reports 6-K 0001178913-26-002274
2026-04-10 3 Ownership 0001178913-26-002070
2026-04-10 3 Ownership 0001178913-26-002068
2026-04-10 3 Ownership 0001178913-26-002066
2026-04-10 3 Ownership 0001178913-26-002064
2026-04-10 3 Ownership 0001178913-26-002062
2026-04-10 3 Ownership 0001178913-26-002060
2026-03-31 3 Ownership 0001178913-26-001962
2026-03-31 3 Ownership 0001178913-26-001960
2026-03-23 20-F Financial reports 20-F 0001178913-26-001593
2026-03-20 6-K Current reports 6-K 0001178913-26-001571
2026-03-19 6-K Current reports 6-K 0001178913-26-001550
2026-02-17 SCHEDULE 13G/A Ownership 0001211060-26-000005
2026-02-10 SCHEDULE 13G/A Ownership 0001995601-26-000002
2025-11-21 6-K Current reports 6-K 0001178913-25-003932
2025-08-22 6-K Current reports 6-K 0001178913-25-003015
2025-08-14 6-K Current reports 6-K 0001178913-25-002894
2025-08-11 SCHEDULE 13G/A Ownership 0001995601-25-000004
2025-08-07 SCHEDULE 13G/A Ownership 0000895421-25-000497
2025-08-07 SCHEDULE 13G Ownership 0000895421-25-000481
2025-07-25 6-K Current reports 6-K 0001178913-25-002465
2025-07-25 424B5 Registrations and prospectuses 0001178913-25-002461
2025-07-01 6-K Current reports 6-K 0001178913-25-002278
2025-06-23 SCHEDULE 13D/A Ownership 0000947871-25-000624
2025-05-27 6-K Current reports 6-K 0001178913-25-001967
2025-05-15 6-K Current reports 6-K 0001178913-25-001807